<DOC>
	<DOCNO>NCT00924365</DOCNO>
	<brief_summary>Background : - About 10,000 child United States live HIV infection since birth . Little known long-term effect HIV infection treatment growth development child . - Because disease , many child HIV face additional difficulty health , well-being development , success school peer relationship . Objectives : - To good understand HIV infection medicine use treat affect growth development child , adolescent young adult infect since birth young . - To develop way improve quality life individual . Eligibility : -HIV-infected patient follow pediatric HIV program NCI December 2004 , HIV-infected sibling participant . Design : - Periodic evaluation pubertal development ; bone mineralization ; body composition fat distribution ; liver , kidney heart status ; behavioral , cognitive academic vocational outcome study group . Evaluations include follow : - Physical examination , include height weight measurement skin-fold thickness test measure body fat . - Review medical record family history . - Blood urine test , include pregnancy test female bear child . - DEXA scan ( X-ray test measure bone strength much fat , muscle bone body ) . - Neuropsychological testing , include evaluation language , think problem-solving ability . - Magnetic resonance imaging ( MRI ) : Test use magnetic field radio wave examine brain structure function . - Oral glucose tolerance test : Blood sample one time subject drink sugary solution measure body 's ability use sugar</brief_summary>
	<brief_title>Natural History Study HIV Acquired Infancy Childhood</brief_title>
	<detailed_description>Background : Highly active antiretroviral therapy ( HAART ) alter natural history HIV disease child . The pediatric cohort country offer tremendous opportunity understand effect HIV ARTs key developmental maturational process . A thorough understanding impact HIV ARTs long-term process extremely relevant ART program HIV-infected child develop around world . Objective : To explore clinical feature impact HIV infection antiretroviral therapy HIV-infected pediatric cohort . Eligibility : Known HIV disease follow NCI pediatric HIV program December 2004 , HIV-infected sibling participant . Elgibility cardiac sub-study expand include person HIV acquire infancy young childhood old 7 meet inclusion criterion . Eligibility cardiac sub-study also include HIV uninfected subject ( 18-30 year age ) server control group . Design : Serial evaluation pubertal development , bone mineralization , body composition fat distribution , hepatic , renal , cardiac status , behavioral , cognitive , academic/vocational outcome . Findings may share multicenter Pediatric HIV/AIDS Cohort Study lead intensive , focused substudies .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>INCLUSION CRITERIA : Known HIV disease follow NCI pediatric HIV program ( NCI protocol ) December 2004 , HIVinfected sibling participant . Age great 6 year . For child great 7 year , ability give assent developmentally appropriate . Receives care health care provider affiliate protocol . INCLUSION CRITERIA FOR CARDIAC IMAGING SUBSTUDY : HIV positive participant Known HIV disease , document believe acquire first decade life Age great 7 year old HIV negative participant HIV negative , documented negative ELISA Age great equal 18 year old less equal 30 year old EXCLUSION CRITERIA : Inability unwillingness provide inform consent subject great equal 18 year , inability unwillingness one parent/legal guardian provide consent subject less 18 year . Clinically significant , systemic illness ( serious infection significant cardiac , pulmonary , hepatic organ dysfunction ) judgment Principal Investigator would compromise patient ability tolerate study . EXCLUSION CRITERIA FOR CARDIAC IMAGING SUBSTUDY : Subjects contraindication MRI scanning . These include limited presence implant device incompatible MRI . Subjects tolerate MRI scan require sedation MRI . Pregnant lactate woman . History severe allergic reaction gadolinium contrast agent . Estimated glomerular filtration rate le 60 cc/min/1.73m ( 2 ) . Inability unwillingness provide inform consent subject great 18 year , inability unwillingness one parent/legal guardian provide permission subject less 18 year . Clinically significant , systemic illness ( serious infection significant cardiac , pulmonary , hepatic organ dysfunction ) judgement Principanl Investigator ( designee ) would compromise patient ability tolerate study Some subject may exclude cardiac CT still eligible enroll rest study . Exclusion criterion cardiac CT component include : Age le 18 year Use metformincontaining product less 24 hour prior contrast administration History Multiple Myeloma Some subject may exclude receive contrast noncontrast cardiac CT. Exclusion receive contrast include : Cratinine value great 1.4 mg/dL History significant allergic reaction CT contrast agent Some subject may receive cardiac CT exclude receive betablocker . Exclusion criterion receive betablocker include : Asthma Active bronchospasm Moderate severe COPD 2nd 3rd degree AV block Decompensated cardiac failure Allergy beta blocker Systolic blood pressure le 100 mm HG Resting heart rate time scan le 60 regular less 65 irregular</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 22, 2014</verification_date>
	<keyword>Children</keyword>
	<keyword>AIDS</keyword>
	<keyword>Toxicity</keyword>
	<keyword>Development</keyword>
	<keyword>Puberty</keyword>
	<keyword>HIV</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>HIV Infections</keyword>
</DOC>